Late appearing 5q--marker in refractory anemia

Area of Science:

• Hematology
• Cytogenetics
• Oncology

Background:

• Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
• The 5q--syndrome is a specific subtype of MDS characterized by a deletion on the long arm of chromosome 5 (del(5q)).
• Diagnosis typically relies on cytogenetic detection of the characteristic chromosomal abnormality.

Observation:

• A patient with clinical features indistinguishable from the 5q--syndrome was studied.
• Initial cytogenetic analysis of bone marrow cells revealed no clonal chromosome abnormalities.
• Subsequent sampling three years later showed the presence of del(5q) in all analyzed metaphases.

Findings:

• The del(5q) chromosomal abnormality was not detected at the initial presentation.
• The characteristic del(5q) deletion emerged over a three-year period.
• This case suggests that the development of the 5q--syndrome may involve sequential genetic events.

Implications:

• The findings indicate that submicroscopic genetic alterations may precede the visible chromosomal rearrangement (del(5q)).
• This challenges the notion that del(5q) is the sole initiating event in the 5q--syndrome.
• Further research into early, submicroscopic genetic changes in MDS is warranted for improved diagnostic and therapeutic strategies.